Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of 5-day and 10-day levofloxacin-based triple regimen for Helicobacter pylori eradication
IRCT20250426065481N1Phase 3Completed
- Sponsor
- Babol University of Medical Sciences
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of levofloxacin in Helicobacter pylori infection (2 arms), sponsored by Babol University of Medical Sciences. Started May 2025; status: completed.
02
Drugs
levofloxacin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on IRCT20250426065481N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250426065481N1.